Travis Money
Psychiatric/Mental Health · Greensboro, NCNPI 1225419625
Payments from drug & device makers
Across 18 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$97
- Neurocrine Biosciences, Inc.$84
- Otsuka America Pharmaceutical, Inc.$21
- Alkermes, Inc.$19
- AbbVie$18
- Sunovion Pharmaceuticals Inc.$18
- plus $39 from 3 others
What the payments were for
- Food & beverage$296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 6 | $97 |
| Neurocrine Biosciences, Inc. | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Indivior Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
How this compares
$296 in reported general payments places this provider in the 40th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 12 | $35,229 |
| ClozarilClozapine | 13 | $23,725 |
| Clozapine | 95 | $6,384 |
| Paliperidone ErPaliperidone | 15 | $1,077 |
| Aripiprazole | 23 | $909 |
| Gabapentin | 21 | $669 |
| Quetiapine Fumarate | 38 | $503 |
| Buspirone Hcl | 45 | $471 |
| Lurasidone Hcl | 16 | $465 |
| Divalproex Sodium ErDivalproex Sodium | 22 | $404 |
| Benztropine Mesylate | 29 | $383 |
| Oxcarbazepine | 17 | $359 |
| Prazosin Hcl | 29 | $326 |
| Hydroxyzine Hcl | 19 | $257 |
| Doxepin Hcl | 12 | $250 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Greensboro
- April NandigamGreensboro$88K
- Brittany MitchellGreensboro$12K
- Lisa PoulosGreensboro$10K
- Marian FriedmanGreensboro$9K
- Brian WhiteGreensboro$8K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- Hannah NealeyFuquay Varina$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.